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Purpose: To evaluate the safety and efficacy of fractional photothermolysis (FP) in the treatment of facial wrinkles 
in Asians.
Methods: A total of 27 Korean patients (Fitzpatrick type III or IV) received 2-3 FP treatment sessions (Sellas; Dinona 
Inc., Seoul, Korea) spaced two weeks apart. Treatments were performed at settings of 7 to 9 mJ/microthermal treat-
ment zone (MTZ) and a density of 1000 MTZ/cm
2. Standardized digital photographs were obtained before each 
treatment and three months after the final treatment. The evaluations of clinical photographs were performed by 
three physicians blinded to the study subjects using a five-point grading scale. In addition, the patients’ perceived 
degree of improvement was assessed three months after the final treatment using a five-point grading scale. Side 
effects were monitored at each follow-up visit.
Results: The physicians’ assessed degrees of improvement were excellent in three patients (12%), significant in ten 
(40%), and moderate in seven (28%). The patients’ self-assessed degrees of improvement were excellent in five 
patients (20%), significant in 11 (44%), and moderate in six (24%). Adverse events were limited to transient pain, 
erythema and edema, except in one case of transient postinflammatory hyperpigmentation. 
Conclusions: FP is an effective treatment modality for reducing facial wrinkles with minimal side effects in Asian 
patients. 
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Ablative laser skin resurfacing with either a carbon dioxide 
(CO2) or erbium:yttrium-aluminum-garnet laser is a well- 
accepted treatment modality for facial rejuvenation. 
Complete epidermal ablation with these systems results in 
loss of barrier function and an extended recovery period. 
Patients undergo prolonged erythema, pigmentary alteration, 
infection and in rare cases, fibrosis.
1,2 Because of these po-
tential risks, nonablative technology was developed as a safe 
alternative to ablative technology for creation of a controlled 
thermal injury to the dermis with subsequent neocollagenesis 
and remodeling of scarred skin, but the technique has limited 
efficacy.
3  Fractional photothermolysis (FP) was recently de-
veloped as a safe and effective treatment modality. Fractional 
photothermolysis induces multiple noncontiguous arrays of 
thermal injury to create unique damage patterns called mi-
crothermal treatment zones (MTZ) and characteristically spares 
the tissue surrounding each MTZ.
4 Because the tissue sur-
rounding each MTZ is intact, healing is rapid due to the re-
sidual viable epidermal and dermal cells. The depth of pene-
tration of each MTZ is energy-dependent and can be tailored 
to the characteristics of the treatment area and even more 
appropriately tailored to the condition being treated within 
the same anatomic region (i.e., deeper for acne scarring and 
more superficial for pigmentation).
4  Histologic evaluation of 
the MTZ demonstrates homogenization of the dermal matrix 
and formation of microscopic epidermal necrotic debris, which 
represent the extrusion of damaged epidermal components 
by viable keratinocytes at the lateral margins of the MTZ.
5 
The stratum corneum remains intact during this process, 
thereby maintaining epidermal barrier function.
4 
Although there have been some reports of successful treat-
ment of fine and moderate wrinkles using FP technology,
4,6-8 
there are few prospective studies in Asians. Recently, this laser 
technique was shown to be safe for treating melasma, acne 
scarring and striae in Asian skin.
9,10 The purpose of this study 
was to evaluate the safety and efficacy of FP in the treatment 
of facial wrinkles in Asians.
Materials and Methods
Twenty-five patients (two men and 23 women) with Fitz-
patrick skin type III-IV were enrolled in this study. Their ages 
ranged from 27 to 61 years (mean, 45 years). This prospective 
study was performed in accordance with the ethical guidelines 
and complied with the policies of the local institutional review Korean J Ophthalmol Vol.23, No.4, 2009
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Fig. 1. Assessment results by patients and physicians using a five- 
point grading scale: 0=no change; 1=slight improvement (1-25%); 
2=moderate improvement (26-50%); 3=significant improvement 
(51-75%); and 4=excellent improvement (>75%).
Fig. 2. Specific anatomic locations with visible wrinkle reduction by
self-assessed questionnaires.
board. Written informed consent was obtained from each pa-
tient. Exclusion criteria included known photosensitivity, 
immunocompression, pregnancy or lactation, history of hy-
pertrophic or keloidal scarring, previous filler injections or 
ablative/nonablative laser skin resurfacing procedures, and the 
use of isotretinoin or other physical acne treatments over the 
previous six months. Patients who had any medical illness 
that could influence the wound healing process were also 
excluded.  
Prior to each procedure, the treatment areas were cleansed 
of debris (such as dirt, makeup and powder) using a mild, 
nonabrasive detergent. No blue dye or gel was required to 
accentuate scar contours or to guarantee laser-skin contact. 
A topical anesthetic cream (EMLA; AstraZeneca, Wilmington, 
DE, USA) was applied to the sites under an occlusive dressing 
for 30 minutes and subsequently washed off. Treatment was 
then delivered using a 1550-nm erbium glass laser (Sellas; 
Dinona Inc., Seoul, Korea) equipped with a 15-mm 
handpiece. Fluence of 7 to 9 mJ/cm
2 at densities of 100-200 
MTZ/cm
2 was applied to the regions in eight to ten passes 
to achieve a final treatment density of 1000 MTZ/cm
2. 
Treatment parameters were adjusted based on skin type 
and tolerability. Three successive treatment sessions were 
performed at intervals of two weeks.
Patients were instructed to use a mild cleanser, thermal 
spring water spray mist, and moisturizer several times daily 
after each treatment session. Patients were counseled regarding 
strict sun avoidance and sunblock use after each treatment 
in order to minimize post-inflammatory hyperpigmentation 
(PIH), particularly in those with darker skin phototypes.
7
Therapeutic outcomes were assessed by patient self-assess-
ment of treatment results and standardized digital photography 
at three months after the final treatment. The self-assessed 
level of improvement from patients was evaluated using the 
following five-point grading scale: 0=no change; 1=slight 
improvement (1-25%); 2=moderate improvement (26-50%); 
3=significant improvement (51-75%); and 4=excellent im-
provement (>75%). Patient satisfaction surveys regarding 
the six specific anatomic regions of visible wrinkle reduction 
were recorded at three months after the final treatment. Pho-
tographic documentations using identical camera settings, 
lighting and patient positioning were obtained before and 
three months after the final treatment. Independent clinical 
assessments of the treatment areas were conducted by three 
physicians blinded to the study subjects based on comparative 
photographs using the same grading scale: 0=no change; 1= 
slight improvement (1-25%); 2=moderate improvement (26- 
50%); 3=significant improvement (51-75%); and 4=excellent 
improvement (>75%). Pearson’s correlation was used to exa-
mine the similarity of scoring between the three independent 
observers. The median value of the three scores in each pa-
tient was determined to be the final score of the physicians’ 
assessment. 
All participants were asked to report any local or systemic 
side effects associated with laser treatment. A pain scale of 
0-10 was used to determine the level of pain during the laser 
treatment. No oral analgesic or anxiolytic medications were 
used. 
Results
All patients completed the study, including the three-month 
follow-ups. At three months after the final treatment, five 
patients (25%) reported grade 4, 11 (44%) grade 3, and six 
(24%) grade 2 as their self-assessed level of improvement 
(Fig. 1). As for the physicians’ assessment of clinical photo-
graphs, positive correlations at three months of treatment 
were observed between observer 1 and 2 (r=0.835, p<0.001) 
and observer 1 and 3 (r=0.777, p<0.001), as well as between 
observer 2 and 3 (r=0.471, p=0.018). At three months after 
the final treatment, 13 patients (52%) showed grade 3 or 
higher improvement (Fig. 1). Patient satisfaction surveys pa-H Lee, et al. FRACTIONAL LASER PHOTOTHERMOLYSIS FOR FACIAL WRINKLES
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A  B
Fig. 3. (A) Crow’s feet on a 40-yr-old female before treatment. (B) Disappearance of fine wrinkles after three mon of treatment.
A  B
Fig. 4. (A) Nasolabial folds on a 48-yr-old female before treatment. (B) Visible shallowing of the folds after three mon of treatment.
A  B
Fig. 5. (A) Post-inflammatory  hyperpigmentation and crust following treatment in a 49-yr-old female after two treatment sessions. (B) 
Complete disappearance of pigmentation after three mon of treatment.
ralleled the physicians’ assessments. Three patients with grade 
1 in both the self- and physicians’ assessments were all older 
than 55 years of age and had presented with relatively deep 
wrinkles.
In multiple questionnaires about specific anatomic regions 
of visible wrinkle reduction, crow’s feet was most commonly 
chosen (56%, 14/25) (Fig. 2). At three months after treatment, 
16 out of 20 patients (80%) who had melanocytic pigmentation 
reported an improvement in skin tone evenness with removal 
of unwanted melanocytic proliferation. Five out of five patients 
(100%) who had significant acne scars reported a substantial 
improvement that included softening of scar contours as well Korean J Ophthalmol Vol.23, No.4, 2009
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as reduction of scar depth. 
Case 1
The patient was a 40-year-old woman with Fitzpatrick 
skin type III. Fluence of 9 J/cm2 at a density of 100 MTZ/ 
cm2 was applied to the regions in ten passes. The result was 
evaluated by both the patient and the physicians as grade 3 
improvement. The skin showed tightening with a loss of 
crow’s feet (Fig. 3A and 3B). 
Case 2
The patient was a 48-year-old woman with Fitzpatrick skin 
type III. Fluence of 9 J/cm
2 at a density of 100 MTZ/cm
2 was 
applied to the regions in ten passes. The result was evaluated 
by both the patient and the physicians as grade 3 improvement. 
Improved skin tone evenness and a shallowing of nasolabial 
folds were observed (Fig. 4A and 4B).
The laser treatment was generally well tolerated. All par-
ticipants experienced treatment-related pain with a mean pain 
score of 5.1 (range, 3 to 8). There was no need for extra 
anesthesia or sedation. Side effects were limited and 
transient. All participants reported mild erythema for 
approximately 2-3 days. For most patients, social 
engagements were limited for only 1-2 days. One patient 
developed transient PIH and crust after two cycles of laser 
treatment using 100 MTZ (Fig. 5A). But three months 
after the final treatment, the hyperpigmentation disappeared 
completely without requiring the use of any bleaching 
agent such as hydroquinone or other topical retinol (Fig. 
5B). Other possible complications, such as vesiculation, scar- 
ring, and infection, were not reported.
Discussion
Our data demonstrate that FP is a safe, effective and no-
ninvasive technique to induce improvement of skin tone and 
skin tightening with a reduction in wrinkles. This new tech-
nology has resulted in a procedure that has minimal downtime 
with reliable, predictable results. Fractional photothermolysis 
is effective for both the epidermis and dermis with minimal 
side effects, leaving the stratum corneum intact. Epidermal 
healing at the sites of injury occurred in 24 hours.
5  Only 15 
or 20% of the surface area is generally treated at each treat-
ment session, and this leads to rapid healing aided by the 
surrounding normal skin. Therefore, controlled, limited dermal 
healing initiates a cascade of events in which normalization 
of the collagenesis/collagenolysis cycle occurs. Delivery of 
high fluence permits deeper heating of the dermis to maxi-
mize tissue effect.
The results of our study are consistent with previous reports 
in Caucasians using fractional resurfacing for wrinkles.
4,6-8 
Manstein et al.
4 reported a mild to moderate improvement 
of periorbital wrinkles in 30 subjects at one and three 
months after four consecutive treatments. Geronemus
7 
noted a less impressive result in deeper rhytide using FP, as 
we could see in our study. 
The side effects of treatment in the study reported were 
transient and limited to erythema and edema, except for one 
case of transient PIH. Post-inflammatory hyperpigmentation 
tends to be more common in Asians following laser surgery.
10 
The rate of PIH was as high as 100% in a review of 500 
consecutive patients who underwent CO2 laser resurfacing.
1 
The melanocytes of dark-skinned patients tend to be hyperac-
tive to stimuli such as inflammation. In a retrospective study 
of 37 Chinese patients who were treated with fractional resur-
facing for acne scarring, skin rejuvenation, and pigmentation, 
the overall rates of PIH in wrinkles/pigmentation and acne 
scarring were 12.4% and 7.1%, respectively. The risk of PIH 
among dark-skinned patients tends to be lower with fractional 
resurfacing than with laser resurfacing.
11 Similarly, only one 
case (4%) of PIH transiently developed in our study. 
More recently, Jih  and  Kimyai-Asadi
12 published  data 
from 50 patients with rhytides who responded to Fraxel 
(SR750; Reliant Technologies, Mountain View, CA, USA) 
treatment using a pulse energy of 8 mJ with a density 
setting of 250 MTZ/cm
2  for a final treatment density of 1500 
to 2000 MTZ/cm
2. We used similar pulse energies of 7-9 mJ 
with a lower density setting of 100-200 MTZ/cm
2  for a 
final treatment density of 1000 MTZ/cm
2, in consideration 
of the depth of wrinkles and tolerability to laser treatment. 
In a recent study, FP treatments were performed on the 
eyelid area
13 at a significantly higher energy of 17 to 20 mJ 
and a lower density of 125 MTZ/cm
2. The use of high energy 
and low density seemed to be more effective for the treat-
ment of wrinkles of the eyelid area. Satisfaction was reported 
to be greater in Asian patients at higher energies, but not 
higher densities, as increased densities were more likely to 
produce complications when compared to increased energies.
14 
As Asian skin is relatively thicker than Caucasian skin, if 
a patient is tolerable, higher pulse energies are more effective 
at improving rhytides and skin texture. However, in this study, 
we did not use high energy, as energy over 10 mJ caused too 
much pain for the patients. 
Indeed, one weakness of this study was the lack of long- 
term follow up. Although our study was designed to evaluate 
the short-term results and complications of FP, further pro-
spective long-term work is essential for the development 
of improved methods for better results and to identify the 
potential long-term manifestations.
In conclusion, fractional resurfacing is a safe and effective 
option for the treatment of wrinkles and skin rejuvenation 
in Asians. The skin shows improved skin tone evenness and 
skin tightening with a reduction in wrinkles. Acne scars also 
showed improvement. Resurfacing with FP results in both 
the rejuvenation of skin and a high patient satisfaction and 
self-esteem. The treatment parameters must be continually 
refined to optimize outcomes and minimize side effects.H Lee, et al. FRACTIONAL LASER PHOTOTHERMOLYSIS FOR FACIAL WRINKLES
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